首页> 外文期刊>Molecular and Cellular Endocrinology >Epigenetic processes in sporadic parathyroid neoplasms
【24h】

Epigenetic processes in sporadic parathyroid neoplasms

机译:散发性甲状旁腺肿瘤中的表观遗传过程

获取原文
获取原文并翻译 | 示例
           

摘要

Parathyroid tumors (PTs) are highly variable in their genetic background. Increasing evidence demonstrates that endocrine diseases can be caused by epigenetic alterations. The present review is focused on epigenetic aberrations related to PTs. DNA methylation, posttranslational histone modification, and noncoding RNAs are epigenetic mechanisms involved in parathyroid tumorigenesis. The information in this review has the potential to define epigenetic signatures associated with PTs for future use as diagnostic markers and lead to the development of new epigenetic drugs with therapeutic applications for these tumors. However, several epigenetic aspects regarding the biomarkers involved and their interactions in tumorigenesis on PTs are still unknown. Key to future epigenetic research would be a focus on global epigenetic identification of biomarkers in the different types of PTs, especially in parathyroid carcinoma. Better understanding may be useful for diagnostic and therapeutic uncertainty. (C) 2017 Elsevier B.V. All rights reserved.
机译:甲状旁腺肿瘤(PTS)在其遗传背景中是高度变化的。越来越多的证据表明内分泌疾病可能是由表观遗传改变引起的。本综述专注于与PTS相关的表观遗传畸变。 DNA甲基化,后翻境组蛋白改性和非致rNA是甲状旁腺肿瘤瘤的表观遗传机制。本综述中的信息有可能定义与PTS相关的表观遗传签名,以便将来用作诊断标志物,并导致新的表观遗传药物具有这些肿瘤的治疗应用。然而,关于所涉及的生物标志物的几个表观遗传方面及其对PTS肿瘤内酯的相互作用仍然未知。未来的表观遗传研究的关键将重点关注不同类型的PTS中生物标志物的全球表观鉴定,特别是在甲状旁腺癌中。更好的理解对于诊断和治疗性不确定性可能是有用的。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号